. . . . . . . . . . . . . . . . . . . . "cat(p(HGNC:NSDHL)) => rxn(reactants(a(SCHEM:\"4-methyl,4-carboxycholesta-8(9),24-dien-3beta-ol\"),a(SCHEM:Nadide)),products(a(SCHEM:\"4-methylcholesta-8(9),24-dien-3-one\"),a(CHEBI:NADH),a(SCHEM:\"H+\"),a(CHEBI:\"carbon dioxide\")))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Reactome Pathway" . "Reactome Pathway" . "Other" . "4-methyl,4-carboxycholesta-8(9),24-dien-3beta-ol is decarboxylated and oxidized to form 4-methylcholesta-8(9),24-dien-3-one. 4-methyl,4-carboxycholesta-8(9),24-dien-3beta-ol and NAD+ react to form 4-methylcholesta-8(9),24-dien-3-one, CO2, and NADH + H+. This reaction occurs in the endoplasmic reticulum, catalyzed by NSDHL (Caldas and Herman 2003). Defects in this enzyme are associated with CHILD syndrome (Congenital Hemidysplasia with Ichthyosiform nevus and Limb Defects) (Konig et al. 2000), but cholesterol biosynthesis in cells and tissues from affected individuals has not been characterized. Instead, the mechanism and stoichiometry of the reaction are inferred from biochemical studies of partially purified rat enzyme (Rahimtula and Gaylor 1972)." . . "Selventa" . . . . "2014-07-03T14:29:44.837+02:00"^^ . . .